Search research articles
Contact Us
Filters
Showing results (241-250 of 384) with videos related to
Page
of 39
Sort By:
Journal of Biological Regulators and Homeostatic Agents
|
November 29, 2002
Nerve growth factor serum level is reduced in patients with sensorineural hearing impairment: possible clinical implications
F Salvinelli, M Casale, F Greco, et al.
Nephron
|
January 1, 1995
Oral activated charcoal in patients with uremic pruritus
S Giovannetti, G Barsotti, A Cupisti, et al.
Journal of Human Hypertension
|
March 14, 2008
High serum levels of CXC chemokine ligand 10 in untreated essential hypertension
A Antonelli, P Fallahi, M Rotondi, et al.
Oncology Reports
|
March 9, 2018
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells
P Fallahi, R Foddis, G Elia, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 19, 2005
The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta
A Micera, I Puxeddu, A Lambiase, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 1, 1995
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer
A Antonelli, P Miccoli, M Ferdeghini, et al.
Biochemical and Biophysical Research Communications
|
February 27, 1987
Interaction of the thyrotropin receptor on rat FRTL-5 thyroid cells with thyrotropin and a thyrotropin-stimulating autoantibody from Graves' patients
L Bartalena, G Fenzi, P Vitti, et al.
International Journal of Immunopathology and Pharmacology
|
June 16, 2012
High serum levels of CXC (CXCL10) and CC (CCL2) chemokines in untreated essential hypertension
A Antonelli, P Fallahi, S M Ferrari, et al.
Molecular Medicine Reports
|
June 15, 2018
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide
P Fallahi, R Foddis, G Elia, et al.
La Clinica Terapeutica
|
November 13, 2013
Hepatitis C virus infection and type 2 diabetes
P Fallahi, S M Ferrari, M Colaci, et al.
Page
of 39
Search research articles
Search
Showing results (241-250 of 384) with videos related to
Sort By:
Page
of 39
Journal of Biological Regulators and Homeostatic Agents
|
November 29, 2002
Nerve growth factor serum level is reduced in patients with sensorineural hearing impairment: possible clinical implications
F Salvinelli, M Casale, F Greco, et al.
Nephron
|
January 1, 1995
Oral activated charcoal in patients with uremic pruritus
S Giovannetti, G Barsotti, A Cupisti, et al.
Journal of Human Hypertension
|
March 14, 2008
High serum levels of CXC chemokine ligand 10 in untreated essential hypertension
A Antonelli, P Fallahi, M Rotondi, et al.
Oncology Reports
|
March 9, 2018
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells
P Fallahi, R Foddis, G Elia, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 19, 2005
The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta
A Micera, I Puxeddu, A Lambiase, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 1, 1995
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer
A Antonelli, P Miccoli, M Ferdeghini, et al.
Biochemical and Biophysical Research Communications
|
February 27, 1987
Interaction of the thyrotropin receptor on rat FRTL-5 thyroid cells with thyrotropin and a thyrotropin-stimulating autoantibody from Graves' patients
L Bartalena, G Fenzi, P Vitti, et al.
International Journal of Immunopathology and Pharmacology
|
June 16, 2012
High serum levels of CXC (CXCL10) and CC (CCL2) chemokines in untreated essential hypertension
A Antonelli, P Fallahi, S M Ferrari, et al.
Molecular Medicine Reports
|
June 15, 2018
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide
P Fallahi, R Foddis, G Elia, et al.
La Clinica Terapeutica
|
November 13, 2013
Hepatitis C virus infection and type 2 diabetes
P Fallahi, S M Ferrari, M Colaci, et al.
Page
of 39